NorthWest Biotherapeutics Inc (NWBO)

[hyperopia]

Maverick, I actually agree with your previous sentiment that they may not reach 40 “specials” patients a month. I know that several posters have been throwing around that 45 patients per month number, but it may be time to remind everyone what that PR actually said:

The Sawston facility contains a total of 88,345 square feet on two floors. The initial production capacity comprises two manufacturing suites, occupying approximately 4,400 square feet on the ground floor. These two suites, together with some additional support and storage space, have a potential production capacity of dendritic cell vaccines for about 40 to 45 patients per month, or approximately 450 to 500 patients annually, subject to regulatory approval.

https://nwbio.com/northwest-biotherapeutics-announces-development-completed-for-initial-production-capacity-of-sawston-uk-facility/

I’m not sure that Northwest Bio actually believes that demand will be quite that strong by self-paying patients, but rather it was a statement for the benefit of investors (and maybe regulators) about their initial potential manual production capacity as presently configured.